Artikel
Öffentlich zugänglich
Structure- and ligand-based drug design approaches for neglected tropical diseases
-
Rafael V. C. Guido
Veröffentlicht/Copyright:
22. Mai 2012
Online erschienen: 2012-5-22
Erschienen im Druck: 2012-5-22
© 2013 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Preface
- Natural products from Brazilian biodiversity as a source of new models for medicinal chemistry
- Bioactive cubitane diterpenoids from a Colombian gorgonian species of the genus Eunicea
- Structure- and ligand-based drug design approaches for neglected tropical diseases
- First total synthesis of the (±)-2-methoxy-6-heptadecynoic acid and related 2-methoxylated analogs as effective inhibitors of the Leishmania topoisomerase IB enzyme
- Potent and selective 2-oxoamide inhibitors of phospholipases A2 as novel medicinal agents for the treatment of inflammatory diseases
- Structural and functional impairments of polysialic acid (polySia)-neural cell adhesion molecule (NCAM) synthesized by a mutated polysialyltransferase of a schizophrenic patient
- Balancing life with glycoconjugates: Monitoring unfolded protein response-mediated anti-angiogenic action of tunicamycin by Raman spectroscopy
- Exploring metal-driven stereoselectivity of glycopeptides by free-energy calculations
- Why are the low-energy protein normal modes evolutionarily conserved?
- IUPAC/CITAC Guide: Investigating out-of-specification test results of chemical composition based on metrological concepts (IUPAC Technical Report)
Artikel in diesem Heft
- Preface
- Natural products from Brazilian biodiversity as a source of new models for medicinal chemistry
- Bioactive cubitane diterpenoids from a Colombian gorgonian species of the genus Eunicea
- Structure- and ligand-based drug design approaches for neglected tropical diseases
- First total synthesis of the (±)-2-methoxy-6-heptadecynoic acid and related 2-methoxylated analogs as effective inhibitors of the Leishmania topoisomerase IB enzyme
- Potent and selective 2-oxoamide inhibitors of phospholipases A2 as novel medicinal agents for the treatment of inflammatory diseases
- Structural and functional impairments of polysialic acid (polySia)-neural cell adhesion molecule (NCAM) synthesized by a mutated polysialyltransferase of a schizophrenic patient
- Balancing life with glycoconjugates: Monitoring unfolded protein response-mediated anti-angiogenic action of tunicamycin by Raman spectroscopy
- Exploring metal-driven stereoselectivity of glycopeptides by free-energy calculations
- Why are the low-energy protein normal modes evolutionarily conserved?
- IUPAC/CITAC Guide: Investigating out-of-specification test results of chemical composition based on metrological concepts (IUPAC Technical Report)
